麻豆传媒

Dermatology >

Atopy

News, opinions and meeting coverage in dermatology.

Fall Derm over a photo of the Wynn, Las Vegas, NV

Chronic Itch: New Therapy, Complexities

"End of the antihistamine era" as new strategies target neural mechanisms

Salt Accumulation May Be a Factor in Atopic Dermatitis

But hypothesis regarding sodium chloride levels in skin needs more work, expert says

Skin-Stripping Test Promising for Inflammatory Skin Diseases

Protein analysis may help differentiate between eczema, psoriasis

Conjunctivitis Seen in Patients on Dupixent

Effectiveness of agent against atopic dermatitis also makes eyes vulnerable

Naltrexone May Be of Use for Chronic Skin Diseases

Benefit with low-dose treatment seen in various case reports, series

Serious Infection Risk with Biologics for Atopic Dermatitis

Double the risk associated with systemic nonbiologics

A Lot of Eczema Quackery from Dr. YouTube

One-third of the site's videos about atopic dermatitis had misleading information

Using Biology of Atopic Dermatitis to Improve Therapy

Following psoriasis model of molecular targeting

AAD 2018: Emphasis on 'Adult' Education, Engagement

More hands-on sessions, direct participant involvement

Allergens Common in 'Hypoallergenic' Moisturizers

Sold as treatments for eczema, could actually worsen the condition

Thyroid Screening Advised for Some Kids with Alopecia Areata

Those with atopy, Down syndrome, and familial history may be at increased risk

Dramatic Responses to Biologic in Atopic Dermatitis

High marks for dual cytokine inhibitor in adults, children

Make the Diagnosis: More Than A Rash

Case Findings: A 51-year-old woman visited her primary care doctor complaining of a rash, pruritus, myalgias, and muscle weakness that made normally easy tasks like standing from a seated position difficult. The rash was an erythematous blanching patch, spread across her back and shoulders like a shawl and across her chest in a V shape. She had also noticed that her fingernail folds were red and swollen. What is your diagnosis?

Positive Data for New Atopic Dermatitis Drugs

Topical PDE4 inhibitor, anti-IL-31 antibody improve signs, symptoms

Derms Want NP/PA Practice Limits

NPs and PAs who bill Medicaid as independent practitioners are more likely to bill for a dermatology visit than for any other office-based service -- so much so that in 2012, 55% of their Medicaid billings were for derm codes, to which dermatologists claim scope of practice violations.

Severe Eczema Eases with Novel Biologic

SAN DIEGO -- The novel monoclonal antibody dupilumab dramatically cut the severity of moderate-to-severe adult atopic dermatitis, a phase II trial showed.

Prime Time: Skin Docs Name 5 Unnecessary Procedures

The American Academy of Dermatology joined more than 80 other medical societies in the Choosing Wisely campaign, naming five treatments or procedures that may not be necessary. Prime Time is a blog by Chris Kaiser for those interested in primary care.

IL-4 Antibody Tames Atopic Dermatitis

MIAMI BEACH -- Atopic dermatitis disease activity declined significantly in patients treated with a monoclonal antibody directed against interleukin-4, according to pooled data from preliminary clinical trials.